Structures by: Peeters O. M.
Total: 86
3-Decyl-5-octyl 2,6-dimethyl-4-(3'-pyridyl)-1,4-dihydropyridine- 3,5-dicarboxylate
C32H50N2O4
New Journal of Chemistry (2005) 29, 12 1567
a=22.8754(7)Å b=16.1015(12)Å c=8.7774(16)Å
α=90.00° β=90.021(7)° γ=90.00°
C10H15N3O4
C10H15N3O4
Acta Crystallographica Section B (1992) 48, 1 95-103
a=7.4013(4)Å b=8.7563(5)Å c=17.3920(10)Å
α=90° β=90° γ=90°
(+)-(3S,4R)-cis-4-amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-1-ium-4-yl) benzamide hydrogen (2R,3R)-dihydroxybutanedioate monohydrate
C14H21ClN3O31,C4H5O61,H2O
Acta Crystallographica Section E (2002) 58, 10 o1169-o1171
a=7.6086(4)Å b=10.6640(10)Å c=14.0482(6)Å
α=90.00° β=93.980(6)° γ=90.00°
Diethyl 4-(4-bromophenyl)-6-methylthieno[2,3-b]pyridine-2,5-dicarboxylate
C20H18Br1N1O4S1
Acta Crystallographica Section E (2003) 59, 3 o384-o386
a=7.8114(6)Å b=11.2988(6)Å c=45.353(2)Å
α=90.00° β=90.00° γ=90.00°
6-Methyl-4-phenylthieno[2,3-b]pyridine-2,5-dicarboxylic acid
C16H11N1O4S1
Acta Crystallographica Section E (2003) 59, 4 o450-o452
a=13.3208(5)Å b=12.5015(4)Å c=8.9448(4)Å
α=90.00000° β=102.859(3)° γ=90.00000°
Ethyl 5-ethoxymethylene-2-methyl-6-oxo-4-phenyl-1,4,5,6-tetrahydropyridine-3- carboxylate
C18H21NO4
Acta Crystallographica Section E (2003) 59, 2 o230-o231
a=22.6520(10)Å b=10.5508(3)Å c=15.7162(7)Å
α=90.00000° β=114.921(4)° γ=90.00000°
2,5-diethoxycarbonyl-6-methyl-4-phenylthieno[2,3-b]pyridine
C20H19NO4S
Acta Crystallographica Section E (2003) 59, 3 o321-o323
a=7.7809(4)Å b=9.8572(4)Å c=24.5480(10)Å
α=90.00000° β=97.222(5)° γ=90.00000°
C14H13N1O3
C14H13N1O3
Acta Crystallographica, Section E (2001) 57, o638-o640
a=12.6506(6)Å b=10.1894(5)Å c=19.8565(12)Å
α=90.00000° β=107.160(5)° γ=90.00000°
(R)-1-{(2-Oxo-1,2-dihydroquinolin-6-yl)[3-(trifluoromethyl)phenyl]methyl}- 1H-1,2,4-triazol-4-ium bromide
C19H14F3N4O1,Br1
Acta Crystallographica Section E (2001) 57, 7 o655-o656
a=7.058(4)Å b=16.212(8)Å c=17.029(9)Å
α=90.00° β=90.00° γ=90.00°
N-{4-[(1S,2S)-2-(Dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl}- 2-benzothiazolamine
C21H23N5S1
Acta Crystallographica Section E (2001) 57, 8 o723-o724
a=9.4442(9)Å b=13.7250(10)Å c=15.7030(10)Å
α=90.00° β=90.00° γ=90.00°
2-[(4-Carboxyphenyl)amino]-4-chlorobenzoic acid monohydrate
C14H10ClNO4,H2O
Acta Crystallographica Section E (2001) 57, 6 o542-o543
a=16.0658(9)Å b=3.9597(2)Å c=21.4730(10)Å
α=90.00000° β=90.619(6)° γ=90.00000°
(+)-1-[(R)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionyl]- 4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)- 1,3-dioxolan-4-yl]methoxy}phenyl)piperazine methanol solvate
C34H33Cl2F3N4O5,CH4O
Acta Crystallographica Section E (2006) 62, 1 o191-o192
a=8.3890(10)Å b=14.7550(10)Å c=14.473(2)Å
α=90.00° β=100.470(10)° γ=90.00°
(+)-1-[(2S)-2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- 1H-imidazole mononitrate
C18H15Cl4N2O1,NO31
Acta Crystallographica Section E (2004) 60, 3 o365-o366
a=13.230(10)Å b=9.191(7)Å c=18.30(2)Å
α=90.00000° β=110.63(8)° γ=90.00000°
(+)-cis-1-Acetyl-4-[4-[[(2R,4S)-2-(2,4-dichloro-phenyl) -2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine,
C26H28Cl2N4O4
Acta Crystallographica Section E (2004) 60, 3 o367-o369
a=10.3740(5)Å b=10.8633(7)Å c=13.2251(4)Å
α=67.725(3)° β=79.262(4)° γ=65.743(4)°
9β,11β-Epoxy-3β-hydroxy-5α-androstan-17-one
C19H28O3
Acta Crystallographica Section E (2001) 57, 1 o39-o40
a=7.3171(3)Å b=10.6462(6)Å c=21.0401(14)Å
α=90.00° β=90.00° γ=90.00°
9α-chloro-3β,11β-dihydroxy-5α-androstan-17-one
C19H29ClO3
Acta Crystallographica Section E (2001) 57, 2 o166-o167
a=8.3450(3)Å b=8.5536(3)Å c=12.6875(5)Å
α=90.00° β=105.482(3)° γ=90.00°
(25R)-3beta-bromo-6beta-acetoxy-5alfa-spirostan-23-one
C29H43BrO5
Acta Crystallographica Section C (1999) 55, 4 601-603
a=9.2654(12)Å b=10.6629(14)Å c=27.703(4)Å
α=90.00° β=90.00° γ=90.00°
3,3,6,6-tetramethyl-9-(3-nitrophenyl)-3,4,5,6,10-hexahydroacridine- 1,8(2H,7H)-dione
C23H26N2O4
Acta Crystallographica Section C (1999) 55, 4 596-599
a=11.8787(8)Å b=15.4830(10)Å c=12.3467(8)Å
α=90.° β=108.210(10)° γ=90.°
Methyl-4β-bromine-7α-cathyloxy-3-oxo-5β-cholanoate
C28H43BrO6
Acta Crystallographica Section C (1999) 55, 4 599-601
a=7.7585(5)Å b=15.6060(10)Å c=22.8759(9)Å
α=90.00° β=90.00° γ=90.00°
Cis-2-sec-Butyl-4-[4-(4-{4-[2-(2,4-dichlorophenyl)- 2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxy]phenyl}- piperazin-1-yl)phenyl]-2,4-dihydro-1,2,4-triazol-3-one
C35H38Cl2N8O4
Acta Crystallographica Section C (1996) 52, 9 2225-2229
a=8.6202(3)Å b=20.154(1)Å c=21.0425(9)Å
α=73.497(4)° β=89.067(3)° γ=79.781(4)°
3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2-methyl- 4H-pyrido[1,2-a]pyrimidine-4-one
C23H24F1N3O2
Acta Crystallographica Section C (1995) 51, 3 533-535
a=17.144(1)Å b=11.450(3)Å c=10.179(2)Å
α=90.00° β=90.757(8)° γ=90.00°
1-(2,3-Dideoxy-3-fluoro-β-D-erythro-pento-furanosyl)-5-fluorouracil
C9H10F2N2O4
Acta Crystallographica Section C (1992) 48, 3 590-592
a=5.8653(2)Å b=11.1843(7)Å c=15.9975(12)Å
α=90° β=93.308(4)° γ=90°
1,8-Dimethyl-2-[(3-furoyl)aminomethyl]-5-phenyl- 2,3-dihydro-1H-1,4-benzodiazepin-4-ium Chloride
C23H24N3O21,Cl11
Acta Crystallographica Section C (1996) 52, 3 691-692
a=6.1780(10)Å b=13.787(2)Å c=24.819(6)Å
α=90.00° β=90.00° γ=90.00°
2-Methylthio-10,11-dihydro-11-(4-methylpiperazin-1-yl)dibenzo[b,f]thiepine maleic acid
C20H25N2S21,C4H3O41
Acta Crystallographica Section C (1995) 51, 4 777-780
a=10.206(2)Å b=9.692(1)Å c=24.498(1)Å
α=90.00° β=91.91(2)° γ=90.00°
C24H20As11,C9H11N3O6S1Tc11,C1H1Cl3
C24H20As11,C9H11N3O6S1Tc11,C1H1Cl3
Acta Crystallographica Section C (1997) 53, 4 449-451
a=9.484(5)Å b=10.949(7)Å c=35.744(20)Å
α=90.00(0)° β=93.87(4)° γ=90.00(0)°
1,8-Dimethyl-5-(4-fluorophenyl)-2-(p-toluolylaminomethyl)-2,3-dihydro- 1H-1,4-benzodiazepine Monohydrate.
C26H26F1N3O1,H2O1
Acta Crystallographica Section C (1997) 53, 1 95-97
a=13.6293(6)Å b=10.364(1)Å c=33.859(2)Å
α=90.00° β=100.236(3)° γ=90.00°
(-) Diphenyl (R)-1-[(S)-isoleucyl]pyrrolidine-2-phosphonate hydrochloride
(C22H30N2O4P1),Cl
Acta Crystallographica Section C (1997) 53, 12 1952-1954
a=6.0144(6)Å b=13.8744(8)Å c=27.517(2)Å
α=90.00° β=90.00° γ=90.00°
1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]- 1H-benzimidazol-2-amine
C28H31FN4O
Acta Crystallographica Section C (1995) 51, 10 2132-2135
a=49.34(1)Å b=10.675(2)Å c=9.372(2)Å
α=90.00° β=98.22(2)° γ=90.00°
1,8-Dimethyl-2-[(3-furancarbonyl)aminomethyl]-5-phenyl- 2,3-dihydro-1H-1,4-benzodiazepin-4-ium Chloride
C23H24N3O21,Cl11
Acta Crystallographica Section C (1995) 51, 10 2177-2179
a=7.653(4)Å b=15.98(1)Å c=17.57(1)Å
α=90.00° β=90.00° γ=90.00°
(+)-(S)-4-[(2-Benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]- piperidineethanol
C22H25F2N3O2S
Acta Crystallographica Section C (1995) 51, 10 2129-2132
a=8.5973(5)Å b=16.5920(8)Å c=30.202(2)Å
α=90.00° β=90.00° γ=90.00°
trans-dichlorobis(metronidazole)palladium(II)
C12H18Cl2N6O6Pd
Acta Crystallographica Section C (1994) 50, 2 180-181
a=7.134(3)Å b=20.971(6)Å c=7.635(2)Å
α=90° β=122.280(10)° γ=90°
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl- 1-piperidinebutanamide-N-oxide
C29H33Cl1N2O3,2.25H2O
Acta Crystallographica Section C (1996) 52, 8 2100-2102
a=17.0543(7)Å b=9.6959(6)Å c=35.025(2)Å
α=90° β=96.813(4)° γ=90°
C24H25FN4O2
C24H25FN4O2
Acta Crystallographica Section C (1992) 48, 10 1827-1830
a=19.950(10)Å b=9.782(5)Å c=22.070(10)Å
α=90.0° β=102.82(3)° γ=90.00°
(+)-(S{R[R-(R)]})-α,α-[Iminobis(methylene-6-fluoro-3,4-dihydro -2H-1-benzopyran-2-methanol)] Hydrobromide Dihydrate
C22H30Br1F2N1O6
Acta Crystallographica Section C (1993) 49, 12 2154-2157
a=4.841(4)Å b=14.617(7)Å c=33.460(10)Å
α=90.00° β=90.00° γ=90.00°
(^+^~-~)-(R^*^{S^*^[S^*^-(S^*^)]})-α,α-[Iminobis(methylene-6-fluoro- 3,4-dihydro-2H-1-benzopyran-2-methanol] Hydrochloride
C22H27Cl1F2N1O4
Acta Crystallographica Section C (1993) 49, 12 2154-2157
a=8.110(9)Å b=9.070(10)Å c=15.61(2)Å
α=81.37(9)° β=85.29(9)° γ=68.61(9)°
(-)-α-[(2-acetyl-5-methylphenyl)amino]-2,6-dichlorobenzeneacetamide
C17H16Cl2N2O2
Acta Crystallographica Section C (1993) 49, 11 1961-1963
a=7.3416(8)Å b=10.3924(8)Å c=21.509(2)Å
α=90.00000° β=90.00000° γ=90.00000°
(+)-6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-methyl-1H- benzotriazole
C16H13Cl1N6
Acta Crystallographica Section C (1993) 49, 11 1958-1961
a=5.1160(10)Å b=10.572(2)Å c=28.870(10)Å
α=90.00000° β=90.00000° γ=90.00000°
(+)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-methyl-1H- benzotriazole Hydrobromide Monohydrate
C16H14Cl1N6,Br1,H2O1
Acta Crystallographica Section C (1993) 49, 11 1958-1961
a=6.008(3)Å b=8.401(4)Å c=35.92(2)Å
α=90.00000° β=90.00000° γ=90.00000°
N-[2-(3-Methoxyphenoxy)propyl]-m-tolylacetamidinium p-Toluenesulfonate Monohydrate
C19H25N2O21,C7H7O3S1,H2O
Acta Crystallographica Section C (1995) 51, 5 991-993
a=8.217(7)Å b=31.54(1)Å c=10.384(4)Å
α=90.00° β=98.09(4)° γ=90.00°
2,5-dimethyl-4-nitroimidazole
C5H7N3O2
Acta Crystallographica Section C (1994) 50, 4 558-559
a=7.7240(10)Å b=10.5130(10)Å c=16.034(3)Å
α=90.00° β=90.00° γ=90.00°
3-methyl-4-phenyl-4-piperidinecarboxylic acid hydrobromide
C13H18BrNO2
Acta Crystallographica Section C (1994) 50, 4 560-562
a=6.9898(8)Å b=7.3709(8)Å c=13.410(2)Å
α=90.00° β=97.460(10)° γ=90.00°
3-methyl-4-phenyl-4-piperidinecarboxylic acid hydrobromide
C13H18BrNO2
Acta Crystallographica Section C (1994) 50, 4 560-562
a=9.711(2)Å b=9.928(2)Å c=13.765(2)Å
α=90.00° β=90.00° γ=90.00°
3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl}- 6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
C23H27F1N4O2
Acta Crystallographica Section C (1993) 49, 9 1698-1700
a=14.240(10)Å b=9.767(7)Å c=16.590(10)Å
α=90.00000° β=113.74(6)° γ=90.00000°
Cis-4-Amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]- 3-methoxy-4-piperidylium}-2-methoxybenzamide tartrate
C23H30Cl1F1N3O41,C4H5O61
Acta Crystallographica Section C (1997) 53, 5 597-599
a=8.7641(4)Å b=26.785(2)Å c=12.5316(7)Å
α=90.00° β=104.412(4)° γ=90.00°
(-)-(2S)-1,7-Dimethyl-5-phenyl-2-(3-thenoylaminomethyl)-2,3-dihydro-1H- 1,4-benzodiazepin-4-ium Chloride
C23H24N3O1S11,Cl11
Acta Crystallographica Section C (1998) 54, 8 1133-1137
a=6.3344(2)Å b=13.5131(7)Å c=25.693(2)Å
α=90.00° β=90.00° γ=90.00°
(-)-(2S)-5-(2-Fluorophenyl)-1-methyl-2-(3-thenoylaminomethyl)-2,3-dihydro- 1H-1,4-benzodiazepin-4-ium Chloride
C22H21F1N3O1S11,Cl11
Acta Crystallographica Section C (1998) 54, 8 1133-1137
a=6.4494(6)Å b=15.0000(10)Å c=21.3340(10)Å
α=90.00° β=90.00° γ=90.00°
(-)-(2S)-5-(4-Fluorophenyl)-1,8-dimethyl-2-(p-toluoylaminomethyl)-2,3-dihydro- 1H-1,4-benzodiazepin-4-ium Chloride Methyl isobutyl ketone solvate
C26H27F1N3O11,Cl1,0.5C6H12O1
Acta Crystallographica Section C (1998) 54, 8 1133-1137
a=11.9932(3)Å b=19.6670(10)Å c=12.9428(7)Å
α=90.00° β=117.471(4)° γ=90.00°
C3H3N3O2
C3H3N3O2
Acta Crystallographica Section C (1993) 49, 4 693-695
a=6.9559(4)Å b=9.9130(6)Å c=7.3045(4)Å
α=90° β=119.41(4)° γ=90°
C11H12N4O2
C11H12N4O2
Acta Crystallographica Section C (1993) 49, 4 763-765
a=6.962(4)Å b=13.754(7)Å c=22.974(12)Å
α=90° β=90° γ=90°
5-nitro-2-aldoxime
C5H4N2O4
Acta Crystallographica Section C (1995) 51, 7 1304-1306
a=5.3330(4)Å b=5.6330(6)Å c=21.203(3)Å
α=90.00° β=90.00° γ=90.00°
4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)- 1-methylpiperidinium hydrogen malate
C19H22N1S11,C4H5O51
Acta Crystallographica Section C (1995) 51, 7 1435-1438
a=9.973(1)Å b=17.101(2)Å c=25.496(3)Å
α=90.00° β=90.00° γ=90.00°
(-)(4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro [3a,3,2-ef] [2]benzazepin-6-ol hydrobromide
C17H22N1O31,Br11
Acta Crystallographica Section C (1997) 53, 9 1284-1286
a=7.3706(3)Å b=14.3273(7)Å c=15.9318(8)Å
α=90.00° β=90.00° γ=90.00°
2-phenyl-1-methyl-5-nitroimidazole
C10H9N3O2
Acta Crystallographica Section C (1994) 50, 5 761-763
a=11.1270(10)Å b=7.5750(10)Å c=12.0460(10)Å
α=90.00° β=108.850(10)° γ=90.00°
2-(p-aminophenyl)-1-methyl-5-nitroimidazole
C10H10N4O2
Acta Crystallographica Section C (1994) 50, 5 761-763
a=11.8640(10)Å b=7.4340(10)Å c=12.216(2)Å
α=90.00° β=110.050(10)° γ=90.00°
1-methyl-2-methylthio-5-nitroimidazole
C5H7N3O2S1
Acta Crystallographica Section C (1994) 50, 6 919-921
a=7.7690(10)Å b=6.5750(10)Å c=15.258(3)Å
α=90.00° β=95.49(4)° γ=90.00°
2-(5-nitro-2-styryl-1-imidazolyl)ethanol
C13H13N3O3
Acta Crystallographica Section C (1994) 50, 6 921-922
a=7.0880(10)Å b=7.1160(10)Å c=24.935(3)Å
α=90.00° β=95.030(10)° γ=90.00°
1,7-Dimethyl-5-phenyl-2-(3-thenoylaminomethyl)-2,3-dihydro- 1H-1,4-benzodiazepin-4-ium chloride
C23H24N3O1S11,Cl11
Acta Crystallographica Section C (1996) 52, 11 2793-2795
a=10.319(2)Å b=8.933(2)Å c=23.976(2)Å
α=90.00° β=94.92(2)° γ=90.00°
(-)-(R)-N-[3,4-dihydro-2H-1-benzopyran-2-yl)methyl]- N'-(1,4,5,6-tetrahydro-2-pyrimidyl)-1,3-propanediamine dihydrobromide
C17H28N4O12,Br22
Acta Crystallographica Section C (1996) 52, 11 2795-2797
a=7.7033(2)Å b=8.4943(2)Å c=15.4169(5)Å
α=90.00° β=96.201(5)° γ=90.00°
(-)-(2S)-2-[(dimethylaminium)methyl]-1-[(5,6,7,8-tetrahydro-5-oxo-2-naphtyl) acetyl]piperidine chloride
C20H29N2O21,Cl1
Acta Crystallographica Section C (1999) 55, 3 458-461
a=7.3648(5)Å b=8.1825(6)Å c=32.657(2)Å
α=90.00° β=90.00° γ=90.00°
(-)-(2S)-2-[(Methylethylaminium)methyl]-1-[(5,6,7,8-tetrahydro-5-oxo-2- naphthyl)acetyl]piperidine chloride dihydrate
C21H31N2O21,Cl1,2(H2O)
Acta Crystallographica Section C (1999) 55, 3 458-461
a=7.2011(8)Å b=7.6300(6)Å c=41.223(3)Å
α=90.00° β=90.00° γ=90.00°
Structure of 5-nitro-2-furaldehyde-semicarbazone
C6H6N4O4
Acta Crystallographica Section C (1994) 50, 6 948-950
a=9.9430(10)Å b=8.4020(10)Å c=10.2200(10)Å
α=90.00° β=101.180(10)° γ=90.00°
5-(2,4-Dichlorophenyl)-2-[(3-furoyl)aminomethyl]-8-methoxy- 1-methyl-2,3-dihydro-1H-1,4-benzodiazepine p-Toluenesulphonate
C30H29Cl2N3O6S
Acta Crystallographica Section C (1994) 50, 8 1352-1354
a=9.8570(10)Å b=12.0480(10)Å c=18.6205(6)Å
α=81.893(7)° β=130.2390(10)° γ=115.938(8)°
2-(4-Cyanobenzoylaminomethyl)-1-methyl-5-(3-thienyl)-2,3-dihydro- 1H-1,4-benzodiazepine p-Toluenesulphonate
C30H28N4O4S2
Acta Crystallographica Section C (1994) 50, 8 1350-1352
a=7.727(4)Å b=33.04(2)Å c=11.264(6)Å
α=90.00° β=101.57(3)° γ=90.00°
(-) (2S)-1-[(3,4-dichlorophenyl)acetyl]-2-[(1-piperidinylium)methyl]piperidine chloride
C19H27Cl2N2O11,Cl11
Acta Crystallographica Section C (1998) 54, 12 1968-1970
a=7.0585(6)Å b=7.0673(4)Å c=40.530(2)Å
α=90.00° β=90.00° γ=90.00°
(+) (2R)-1-[(3,4-dichlorophenyl)acetyl]-2-[(1-pyrrolidinylium)methyl]piperidine chloride monohydrate
C18H25Cl2N2O1,Cl1,H2O
Acta Crystallographica Section C (1998) 54, 12 1968-1970
a=6.8417(4)Å b=10.2086(5)Å c=14.6099(8)Å
α=90.00° β=101.574(5)° γ=90.00°
(+)-(2R-cis)-10-Bromo-2,3,3a,8-tetrahydro- N,N-dimethyl-dibenz[c,f]isoxazolo[2,3-a]azepine-2-methanamine
C19H21BrN2O
Acta Crystallographica Section C (1999) 55, 5 794-796
a=22.07(2)Å b=4.419(6)Å c=22.29(3)Å
α=90.00° β=127.18(8)° γ=90.00°
3-(2'-hydroxyphenylamino)-5,5-dimethyl-2-cyclohexenone
C14H17NO2
Acta Crystallographica Section C (1999) 55, 6 1029-1031
a=7.208(2)Å b=6.291(4)Å c=14.432(5)Å
α=90° β=104.04(2)° γ=90°
(S)-8-Chloro-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo [4,5,1-jk][1,4]benzodiazepinium-2(1H)-thione Bromide Methanol Solvate
C16H21Cl1N3S11,Br11,C1H4O1
Acta Crystallographica Section C (1999) 55, 8 1322-1325
a=7.498(4)Å b=9.666(5)Å c=28.04(2)Å
α=90.00° β=90.00° γ=90.00°
Trans-5-nitro-2-furanacrylic acid
C7H5N1O5
Acta Crystallographica Section C (1994) 50, 12 1930-1931
a=5.154(4)Å b=14.253(5)Å c=10.400(5)Å
α=90.00° β=99.61(6)° γ=90.00°
O-Isopropyl N-(2-furoyl)thiocarbamate
C9H11NO3S
Acta Crystallographica Section C (2000) 56, 8 1042-1043
a=7.679(4)Å b=7.004(5)Å c=10.372(5)Å
α=90.00° β=107.43(4)° γ=90.00°
P-Formamidebenzoic acid
C8H7N1O3
Acta Crystallographica Section C (2001) 57, 1 86-87
a=8.0595(7)Å b=3.8631(2)Å c=11.8120(10)Å
α=90.00° β=90.160(8)° γ=90.00°
Ethyl methyl 1,4-dihydro-4-(3-nitrophenyl)-2,6-bis(1-piperidylmethyl)pyridine -3,5-dicarboxylate
C28H38N4O6
Acta Crystallographica Section C (2000) 56, 11 1346-1347
a=8.9714(6)Å b=11.7112(11)Å c=26.718(2)Å
α=90° β=97.271(5)° γ=90°
Tribenzylphosphine oxide
C21H21OP
Acta Crystallographica Section C (2000) 56, 3 e98-e99
a=16.685(2)Å b=16.685(2)Å c=5.4680(10)Å
α=90° β=90° γ=120°
5-Amino-6-phenyl-1,6-dihydropyridazin-3(2H)-one
C10H9N3O1
Acta Crystallographica Section C (2000) 56, 3 345-346
a=8.752(2)Å b=10.525(5)Å c=20.619(5)Å
α=90° β=90° γ=90°
3β-acetoxy-5α,6β-dihydroxy-bisnorcholanic acid 22\ρigtharrow16 lactone
C24H36O6
Acta Crystallographica Section C (2000) 56, 1 78-79
a=6.3980(4)Å b=9.7142(5)Å c=35.119(4)Å
α=90.00° β=90.00° γ=90.00°
1-(3-methoxybenzoyl)-3,3-diethylthiourea
C13H18N2O2S
Acta Crystallographica Section C (2000) 56, 4 503-504
a=7.754(4)Å b=8.949(8)Å c=11.251(7)Å
α=78.48(6)° β=70.26(4)° γ=70.06(6)°
(-)-(3S,4R)-1-[4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl- 4-piperidinecarboxylic acid Hydrobromide
C26H30F1N2O21,Br1
Acta Crystallographica Section C (1994) 50, 9 1501-1503
a=6.5920(10)Å b=21.621(4)Å c=16.894(4)Å
α=90.00° β=90.00° γ=90.00°
C10H13FN2O4
C10H13FN2O4
Acta Crystallographica Section C (1990) 46, 10 1934-1936
a=10.6001(7)Å b=6.18470(10)Å c=16.9227(4)Å
α=90° β=98.040(3)° γ=90°
5α-9(11)(16)-pregnadien-3β-ol-20-oxime acetate
C23H33NO3
Acta Crystallographica Section C (2000) 56, 12 e582-e583
a=7.0198(2)Å b=12.0153(5)Å c=24.669(2)Å
α=90.00° β=90.00° γ=90.00°
C18H20F1N1O2,Br
C18H20F1N1O2,Br
Acta Crystallographica Section C (1993) 49, 12 2157-2160
a=7.672(4)Å b=15.37(2)Å c=15.053(9)Å
α=90.° β=90.54(5)° γ=90.°
5α-9(11)-androsten-3β-ol-17-one acetate
C21H30O3
Acta Crystallographica Section C (2000) 56, 12 e582-e583
a=10.1120(10)Å b=7.7821(6)Å c=12.0922(9)Å
α=90.00° β=91.730(10)° γ=90.00°
H14K0.778Mn1.216O25.94S2U4
H14K0.778Mn1.216O25.94S2U4
The Canadian Mineralogist (2008) 46, 173-182
a=8.661Å b=14.375Å c=17.705Å
α=90° β=104.12° γ=90°
Co1.206H14K0.77O26.07S2U4
Co1.206H14K0.77O26.07S2U4
The Canadian Mineralogist (2008) 46, 173-182
a=8.651Å b=14.188Å c=17.713Å
α=90° β=104.14° γ=90°
H14K0.598Ni1.083O26.08S2U4
H14K0.598Ni1.083O26.08S2U4
The Canadian Mineralogist (2008) 46, 173-182
a=8.662Å b=14.095Å c=17.770Å
α=90° β=104.18° γ=90°
H14K0.74O25.95S2U4Zn1.148
H14K0.74O25.95S2U4Zn1.148
The Canadian Mineralogist (2008) 46, 173-182
a=8.650Å b=14.180Å c=17.709Å
α=90° β=104.14° γ=90°
Zippeite
H5KO12SU2
The Canadian Mineralogist (1995) 33, 1091-1101
a=8.755Å b=13.987Å c=17.730Å
α=90° β=104.13° γ=90°